Mesenteric injury after cardiopulmonary bypass: Role of poly(adenosine 5′-diphosphate-ribose) polymerase*

Gábor Szabó, Pál Soós, Susanne Mandera, Ulrike Heger, Christa Flechtenmacher, Leila Seres, Zsuzsanna K. Zsengellér, Falk-Udo Sack, Csaba Szabó, Siegfried Hagl

Critical Care Medicine · 2004 · 11 citations · 25 references

Abstract

PARP inhibition with INO-1001 improves the recovery of myocardial function and prevents mesenteric vascular dysfunction and tissue injury after cardiopulmonary bypass with hypothermic cardiac arrest.

References

25